Holding(s) in Company | 14-Nov-2024 | 09:31 | RNS |
Total Voting Rights | 31-Oct-2024 | 12:25 | RNS |
Holding(s) in Company | 14-Oct-2024 | 15:09 | RNS |
Total Voting Rights | 30-Sep-2024 | 13:44 | RNS |
Holding(s) in Company | 27-Sep-2024 | 09:22 | RNS |
Director/PDMR Shareholding | 24-Sep-2024 | 11:24 | RNS |
US FDA approval: Total Knee Study | 17-Sep-2024 | 14:00 | RNS |
Director/PDMR Shareholding | 12-Sep-2024 | 11:18 | RNS |
Holding(s) in Company | 03-Sep-2024 | 16:20 | RNS |
Director/PDMR Shareholding | 30-Aug-2024 | 15:44 | RNS |
Total Voting Rights | 30-Aug-2024 | 09:16 | RNS |
Holding(s) in Company | 23-Aug-2024 | 15:18 | RNS |
Holding(s) in Company | 09-Aug-2024 | 10:08 | RNS |
Director/PDMR Shareholding | 05-Aug-2024 | 13:56 | RNS |
Director/PDMR Shareholding | 02-Aug-2024 | 11:51 | RNS |
Currency | UK Pounds |
Share Price | 863.00p |
Change Today | -13.00p |
% Change | -1.48 % |
52 Week High | 1,548.00 |
52 Week Low | 831.00 |
Volume | 256,155 |
Shares Issued | 87.03m |
Market Cap | £751.11m |
Beta | 1.57 |
RiskGrade | 112 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 2 |
Total | 12 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 30-May-24 | 25-Jan-24 |
Paid | 28-Jun-24 | 23-Feb-24 |
Amount | 13.42p | 46.14p |
Time | Volume / Share Price |
16:36 | 2,728 @ 863.00p |
16:36 | 12,272 @ 863.00p |
16:35 | 251 @ 863.00p |
16:35 | 70 @ 863.00p |
16:35 | 38 @ 863.00p |
You are here: research